Skip to content
#gene editing Open access

Dynamic reprogramming and A-to-I RNA editing in neutrophils in response to tumor induction.

Sep 2026 · Journal of Biological Chemistry · pp. 113569 · 0 citations
Medicine

TL;DR

Results indicate a possible link between transcriptional remodeling, RNA editing, and functional polarization of HCC-induced neutrophils, and provide an exploratory framework for investigating ADAR-regulated RNA editing in tumor-immune communication.

Abstract

Tumor-associated neutrophils (TANs) play dual roles in cancer progression, yet the molecular basis of their reprogramming by tumor cells remains poorly understood. Here, we performed a time-resolved transcriptomic and RNA editome analysis of neutrophils co-cultured with three hepatocellular carcinoma (HCC) cell lines using 293T cells as control. We observed consistent transcriptional remodeling across treatments, with progressive upregulation of pro-tumor genes and downregulation of anti-tumor genes, which were associated with functions of neutrophil chemotaxis, NETosis, metabolic reprogramming, and N1-to-N2 polarization. Concurrently, global A-to-I RNA editing, ADAR expression, together with ADAR1-MDA5-immunity and ADAR2-recoding axes were markedly reduced in HCC-induced neutrophils, compatible with the tumor-driven reprogramming hypothesis. Differential editing analysis revealed three key downregulated recoding sites with distinct evolutionary histories, MED21 (p.Gln145Arg), HSPA1L (p.Asn153Asp), and ZNF397 (p.Tyr481Cys), which may alter transcriptional and stress-regulatory functions of downstream targets. Together, these results indicate a possible link between transcriptional remodeling, RNA editing, and functional polarization of HCC-induced neutrophils. Since our analyses are in silico, the proposed mechanistic links should be interpreted as hypotheses for future validation. Our findings provide an exploratory framework for investigating ADAR-regulated RNA editing in tumor-immune communication.

Read PDF

Similar papers

#gene editing Open access Oct 2026

CRISPR–Cas9 Editing of Myeloid Lectins Reveals Target-Dependent Transcriptional Remodeling in Tumor-Associated Macrophages

Tumor-associated macrophages (TAMs) integrate multiple microenvironmental signals, including lectin-mediated recognition of tumor-associated glycans. Although several myeloid lectins have been implicated in tumor–macrophage interactions, their contributions to immunosuppressive TAM phenotypes remain poorly defined. We...

Gonçalo Trindade, M. Pinto, G. Domenici et al. · 0 citations
Open access Aug 2026

Single-cell profiling identifies STAT3/NF-κB regulatory hubs and cytokine crosstalk in the tumor microenvironment

Integrative single-cell RNA sequencing analysis of publicly available datasets from non-small cell lung cancer and breast cancer is performed to systematically map transcriptional heterogeneity and regulatory networks within the TME, providing a systems-level framework of TME organization.

M. O. Odubote, Chiemeka Elochi Emeribe · 0 citations
Review Open access Sep 2026

ADAR1 promotes cancer fitness by buffering endogenous RNA sensing.

Tumors exploit multifaceted strategies to survive and avoid destruction by the immune system. The RNA-editing enzyme adenosine deaminase acting on RNA 1 (ADAR1) regulates double-stranded (ds)RNA metabolism by catalyzing the adenosine-to-inosine (A-to-I) change, which is one of the most prevalent RNA modifications in ma...

C. Cerboni, Stefano Petrai, M. Greco et al. · 0 citations
Review Aug 2026

RNA modifications as determinants of cancer cell death: from epitranscriptomic mechanisms to therapeutic targeting

It is argued that while epitranscriptomics represents a compelling regulatory axis in cancer cell death, advancing the field will require integrative, high-resolution, and functionally precise approaches to move beyond correlative frameworks toward mechanistic and clinically actionable insights.

A. Mukherjee, Ankit Kumar Bharti, D. Mathew et al. · 0 citations
Oct 2026

Single-cell transcriptome analysis reveals onco-fetal reprogramming with implications for drug resistance and clinical outcome.

Onco-fetal reprogramming of the tumor ecosystem induces fetal-like characteristics, leading to tumor growth and malignant progression. Here, we develop a robust computational pipeline to systematically identify onco-fetal (OF) cells, using single-cell transcriptomic data from corresponding fetal and tumor tissues acros...

Yong-Le Xu, Shao-Yi Chen, Zheng-Lin Lu et al. · 0 citations
Open access Sep 2026

CRISPRa-identified transcription factors reprogram glioblastoma into dendritic cell-like cells to elicit systemic antitumor immunity

A candidate-based CRISPR activation (CRISPRa) functional screen is developed to identify regulators of conventional dendritic cell (cDC)-fate specification and concludes that the transcription factors Zfp366/Znf366, Pu.1, Irf8, and Batf3 (ZPIB) are sufficient to convert GBM cells into cDC-like cells.

Xiao Liu, Mao-Rong Zhu, Cheng Zou et al. · 0 citations

Related blog posts

Microsoft Research Blog Oct 15, 2026

Proof-based general-purpose computing with Magnetar

Zero-knowledge proofs can verify computing results without rerunning workloads or exposing sensitive data. Magnetar helps bring them into the mainstream with support for standard programming languages, major speed gains, and quantum-resistant security. The post Proof-based general-purpose computing with Magnetar appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.